In recent years, mass spectrometry has moved more than ever before into the front line of protein-centered research. After being established at the qualitative level, the more challenging question of quanti fi cation of proteins and peptides using mass spectrometry has become a focus for further development. In this chapter, we discuss and review the strategies and problems of the methods currently in use for the quantitative analysis of peptides, proteins, and fi nally proteomes by mass spectrometry. The common themes, the differences, and the potential pitfalls of the main approaches are presented in order to provide a survey of the emerging fi eld of quantitative, mass spectrometry-based proteomics.
Introduction
recent years and has engendered a variety of novel MS-based approaches for the quanti fi cation of proteins and peptides. Depending on the question and the sample at hand, they can focus, at the one extreme, on the accurate quanti fi cation of individual peptides or, at the other, on broad comparisons of (nearly) entire proteomes. They can detect and quantify effects of a speci fi c stimulus ranging from changes in the amounts of a single, de fi ned posttranslational modi fi cation to the proteome-wide kinetics of the same modi fi cation between different stages of the cell cycle.
The variety of questions being asked has impelled the development of an array of quantitative MS methods. These can be classi fi ed into two groups, according to the kind of information that they provide: (a) relative quanti fi cation, comparing the amounts of proteins or whole proteomes between samples and yielding a quantitative ratio or relative change (see , and (b) absolute quanti fi cation (see , providing information about the absolute amount or the concentration of a protein within a sample. An alternative classi fi cation can be based on the underlying methodology: (a) approaches based on labeling with stable isotopes (see [17] [18] [19] [24] [25] [26] , involving the arti fi cial labeling of peptides or proteins, and (b) label-free approaches (see Chapters 16 , 20 , and 22 ) , in which the samples retain their native isotope composition and are compared between separate measurements. The fi rst of the two classi fi cations, along with the quanti fi cation methods most commonly used, is summarized in Fig. 1 . A brief description of most of the various methods and their most important advantages and disadvantages is given in Table 1 . These limitations led to the development of quanti fi cation methods based upon labeling with stable isotopes. Owing to the natural occurrence of certain stable heavy isotopes (e.g., 13 C, 15 N, 18 O, 2 H) each peptide/protein contains a certain proportion of these; the isotope pattern seen in the mass spectrometer thus re fl ects the natural abundances of these heavy isotopes within the peptide. Arti fi cial incorporation of heavy isotopes produces a mass shift of the peptide's peaks (including, its largely unchanged isotope pattern) in the mass spectrum. Importantly, additional 13 C, 15 N, and 18 O have little or no impact on the behavior of peptides and proteins during LC or in the mass spectrometer (see Note 1). Thus, intensity ratios of peaks that correspond to different isotopic compositions of the same molecular species re fl ect quantitatively the isotopic abundance ratios in the molecular species concerned. Labeling techniques take advantage of this feature and afford the opportunity to compare directly two or more samples within the same mass spectrum. Label-based approaches offer a higher accuracy of quantitative measurements, but they require additional steps in sample preparation and usually entail higher costs compared with label-free approaches. Additionally, only a limited number of samples can be quanti fi ed within one experiment (from two to eight, depending on the method). Quantitative information can be obtained not only from the MS spectrum comparing intact peptide (or protein) peak intensities, but also from the MS/MS fragment ion spectrum. The advantages of the former are that usually
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more than one independent spectrum is available for analysis, and also that the high peak intensity gives statistically more accurate results. Quanti fi cation of the fragment ion spectrum bene fi ts from the absence of overlapping precursor ion peaks (as in selected ion monitoring, SIM) and from the identical properties of the precursor ion (as in iTRAQ). Nonetheless, fragment ions are generally detected with lower intensities, and often only a single spectrum leads to quanti fi cation. This can impair the accuracy of the quanti fi cation ( 1 ) . At the other end of the scale, too high intensities in the mass spectrometer can lead to detector saturation, again resulting in imprecise measurements ( 2 ) .
Relative quanti fi cation provides calculation of abundance ratios between peptides and proteins by comparing their signals originating from different samples. Usually performed in "discovery" (nontargeted) mode, it allows quantitative pro fi ling of tens of thousands of peptides from thousands of proteins within a single experiment without a priori information (for an example, see ref.
3 ) . As discussed above and in a manner similar to absolute quanti fi cation, it can be based upon heavy isotope labeling or label-free.
Most of the methods for relative quanti fi cation make use of labeling by stable heavy isotopes of 13 C, 15 N, 18 O, and 2 H. Again, the identical physicochemical properties of labeled and native peptides (e.g., in stable isotope labeling with amino acids in cell culture (SILAC)) (see Chapters 13 , 14 , 25 , and 26 ) , or of peptides labeled with physicochemically identical reagents (e.g., in iTRAQ) (see Chapter 8 ) , are exploited for relative comparison of intensities of mass-shifted peaks within the same mass spectrum. These approaches can be divided into three groups, according to the labeling technique: (a) chemical, (b) metabolic, or (c) enzymatic.
The methods for relative quanti fi cation by chemical labeling rely on the chemical reaction (without enzymatic catalysis) between a reagent and the peptides (or proteins) in the sample of interest in vitro (i.e., after isolation of the protein/peptide from the biological sample). The reagent used bears different numbers of stable heavy isotopes and thus produces a mass shift in the MS spectrum (e.g., dimethyl labeling) or MS/MS spectrum (in case of isobaric reagents, e.g., iTRAQ). One of the fi rst chemical labeling approaches is ICAT (isotope-coded af fi nity tags ( 4 ) ) (see Chapter 24 ) . The ICAT chemical label consists of three moieties: a sulfhydryl-reactive group for coupling to the analyte cysteines, an af fi nity group for isolation of the tagged species (peptides), and a linker in light 3. Methods for Protein/Peptide Quanti fi cation
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(with natural isotope distribution) and heavy (containing eight deuterium atoms instead of 1 H) form. Two samples to be compared are labeled with light or heavy ICAT reagent and subsequently mixed. After analysis, the peak intensities of identical peptide pairs labeled with the light and the heavy reagent, respectively, are compared, and their ratio is calculated. Signi fi cant disadvantages of the approach are the side-reactivity of the tag and its inability to label peptides lacking cysteine.
Another labeling method based on the same principle is ICPL (isotope-coded protein labels ( 5 ) ) (see Chapter 11 ) . A signi fi cant advantage of ICPL is their reactivity towards free amines, allowing labeling of virtually all peptides present in the samples. Dimethyl labeling is a similar approach using simpler chemical reagents ( 6, 7 ) . Dimethylation of lysine residues by stable-isotope-labeled formaldehyde and cyanoborohydride allows duplex and triplex relative comparison. This approach is a reliable and inexpensive alternative to the common chemical labeling methods, while offering nearly 100% labeling ef fi ciency in a simple chemical reaction. mTRAQ (Applied Biosystems) is a recent addition to the repertoire of amine-reactive labels. It uses double or triple labeling by stable heavy-isotope-labeled chemical reagents and is designed to be used in SRM assays (although full scan MS-based quanti fi cation is also possible ( 8 ) ). It is speci fi cally applied in biomarker discovery experiments as alternative to labeled standard peptides ( 9 ) .
An important group of reagents used for relative quanti fi cation comprises the isobaric chemical labels. These rely on isobaric labeling of peptides from different samples, which upon fragmentation give rise to different reporter ions in the MS/MS spectrum. The iTRAQ (isobaric tags for relative and absolute quanti fi cation, Applied Biosystems ( 10 ) ) (see Chapter 8 ) labels each contain an amine-reactive group, a balance group, and a reporter group. Overall, different reagents have the same molecular weight and upon labeling produce identical mass shifts. Different samples are labeled with reagents containing different distributions of heavy isotopes between the balance and reporter groups and are subsequently mixed. Identical peptides from the samples to be compared co-elute and are detected as a single precursor ion. The iTRAQ labels are designed in such a way that, upon fragmentation, different reagents give rise to reporter ions with identical chemical composition but different molecular weights, owing to their different isotope compositions. Their intensities are proportional to the relative abundances of the labeled peptide originating from the different samples. A major advantage of this method is that it is capable of "multiplexing"-up to eight samples can be analyzed within a single experiment.
A very similar approach is the labeling with tandem mass tags (TMTs, Thermo Scienti fi c ( 11 ) ) (see Chapter 9 ), which allows comparison of up to six samples. Like iTRAQ tags, TMTs also consist of an amine-reactive, a balance, and a reporter group, which are released upon fragmentation during MS/MS and the intensity of which is used to calculate relative amounts between the samples.
A different approach for quanti fi cation at the MS/MS level is IPTL (isobaric peptide termini labeling ( 12 ) ) (see Chapter 10). This uses isobaric sequential labeling of the C-and N termini of the analyzed peptides with deuterated and non-deuterated reagents. Upon fragmentation, either the N-terminal or the C-terminal label is lost, which results in differentially labeled C-and N-terminal fragment ion series, respectively. These appear as fragment ion pairs in MS/MS and their relative intensities can be used for quanti fi cation. An advantage of this strategy is that the quanti fi cation is based on several data points per MS/MS spectrum, although this complicates data analysis enormously.
A signi fi cant advantage of all chemical labeling methods is that they can be applied to practically any type of sample (cell culture, tissues, body fl uids, etc.), in contrast to metabolic labeling as discussed below. However, it is crucial to optimize labeling conditions (see Note 2).
Metabolic labeling with stable heavy isotope labels introduces the label at the earliest time point in an experiment, i.e., during cell growth and duplication. This is achieved by feeding organisms with special media containing a subset of the metabolites in heavylabeled form. Metabolic labeling ensures lower deviations in quanti fi cation, as the samples to be compared can be mixed at a very early stage during the experiment. Metabolic labeling can easily be achieved in cell culture, but scaling-up to whole organisms such as Drosophila , Caenorhabditis elegans , and even mice is also possible. Labeling with 15 N-containing media (see Chapter 12 ) has been used successfully for quanti fi cation at the level of yeast ( 13 ) , mammalian cells ( 14 ) , C. elegans , Drosophila melanogaster ( 15 ) , Arabidopsis thaliana ( 16 ) , and rat ( 17 ) . Very high levels of isotope incorporation can be achieved by this method, but the mass difference between labeled and unlabeled samples depends on the number of 15 N atoms present in different peptides and presents a signi fi cant challenge for data analysis and quanti fi cation. Moreover, highly enriched 15 N sources are required in order to avoid complex isotope distributions of partially labeled peptides ( 18 ) .
A computationally simpler method was developed to address these issues. SILAC ( 19 ) (see Chapters 13 , 14 , 25 , and 26 ) takes advantage of the fact that organisms are naturally (or genetically manipulated to be) auxotrophic for certain amino acids. These amino acids can therefore be provided in labeled and unlabeled form to growth media and would be used by the organism for building proteins in vivo. SILAC experiments usually employ lysine and arginine containing different numbers of the heavy Metabolic Labeling isotopes 13 C, 15 N, and 2 H. Using trypsin for protein digestion ensures that each resulting peptide will contain at least one labeled amino acid (except for the C-terminal peptide of the protein). By comparison of the intensities of the precursor isotope envelopes of nonlabeled and labeled peptides, quantitative information can easily be obtained. This has been further facilitated by the development of robust and semiautomated computational tools for data analysis, such as the MaxQuant software suite ( 20 ) (see Chapters 13 and 29 ). The SILAC approach can be used to compare simultaneously two or three samples. It has been applied successfully in near-whole proteome quanti fi cation pro fi ling ( 3, 21 ) , in following the kinetic changes of posttranslational modi fi cations ( 22 ) , in separating background from speci fi c interactors in pull-down approaches ( 22, 23 ) , and in pulse-labeling to monitor the proteome-wide changes induced by a speci fi c treatment ( 24 ) . It can be applied not only in cell culture but also to whole organisms such as Drosophila ( 25 ) or mice ( 26 ) .
As with most other label-based approaches, when metabolic labeling is applied nearly 100% incorporation of the label should be aimed at. Incomplete labeling results in inaccurate quanti fi cation. Additionally, any changes or stress in the experimental organism due to the arti fi cial growth medium should be taken into account (e.g., when using dialyzed fetal bovine serum for mammalian cells). Another important consideration when one is using SILAC is the metabolic conversion of the isotopically labeled amino acids within the cell. This can lead to incorrect quanti fi cation if (for example) the pathway leading from arginine to proline is stimulated when the concentration of the added arginine is not carefully adjusted, or if the conversion is not corrected for ( 27 ) (see Note 3). In the case of af fi nity interaction pull-downs using SILAC in vitro, careful adherence to identical conditions for preparation of heavy and light cell extracts is important for obtaining reliable results ( 23 ) . A signi fi cant disadvantage of metabolic labeling methods is their inability to quantify tissues and body fl uids from organisms that cannot be labeled easily (e.g., human patients). In a recent approach aimed at circumventing this issue, internal SILAC standards were added; this allowed successful quanti fi cation in tumor tissue samples ( 28 ) .
Heavy stable isotopes can be incorporated during enzymatic proteolysis of proteins (see Chapter 15 ) . Performing proteolysis in heavy (H 2 18 O) or light (H 2 16 O) water incorporates, respectively, two 18 O or 16 O atoms at the C terminus of the generated peptides, resulting in a mass shift of 4 Da between heavy-and light-labeled peptides ( 29, 30 ) . This label can also be incorporated after digestion in a second incubation step with a protease. This method ensures near-complete labeling and bene fi ts from the absence of side reactions. Acid-catalyzed back-exchange at extreme pH conditions Enzymatic Labeling can occur ( 31 ) (see Note 4); however, the mild conditions used during ESI or MALDI analyses do not in fl uence the stability of the introduced label. Incomplete labeling by incorporation of only one 18 O atom can complicate data analysis and needs to be taken account of ( 32 ) .
Label-based approaches for proteomic quanti fi cation usually come at higher cost and require additional steps of sample preparation. Therefore, it is not surprising that the use of label-free methods has been increasing during the last few years. As mentioned above, label-free quantitative approaches rely on the comparison of different features between independent LC-MS or LC-MS/MS measurements. They fall into two general categories: (a) methods that involve comparing peptide signal intensities at the level of LC-MS analysis (see Chapter 16 ) , and (b) methods that involve counting the number of identi fi ed peptides or acquired fragment spectra (see Chapter 22 ) .
Signal intensities of ions after electrospray ionization correlate with ion concentrations ( 33, 34 ) . The extracted peak areas from chromatograms in LC-MS measurements speci fi c for certain ions (extracted ion chromatograms, XIC) can therefore be used for relative quanti fi cation of speci fi c peptides and proteins between different samples. The method allows measurements with high precision and wide dynamic range, especially when high-resolution mass spectrometers are used. It can also be applied to MALDI measurements combined with of fl ine-LC separation. However, the following important considerations should be taken into account. First of all, the variation between measurements of the peak intensities of peptides from the same sample (technical replicates) should be recorded and appropriate normalization should be applied. Secondly, and more critically, variation of the LC retention time and/or m / z values of identical peptides between measurement runs should be considered. Any variability in this respect requires alignment of individual ion chromatograms for correct quanti fi cation and elimination of any global drift in retention time. Practical normalization strategies may include the addition of identical amounts of standard protein in different sample or normalization, based on a priori information about a protein that does not change quantitatively between the samples compared ( 1 ) . Reproducibility of LC separation, stability of the electrospray ion source, and the use of computational algorithms for comparison, alignment, and statistical evaluation of several LC-MS datasets in a single procedure are therefore crucial (see Note 5).
The second category of label-free quanti fi cation methods relies on the practical observation that more abundant peptides are more likely to be observed and detected in an MS experiment.
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These approaches use the number of peptides or the number of fragment spectra observed for a particular protein in the analysis. However, Liu et al. found a linear correlation over two orders of magnitude between the number of spectra and the relative protein abundance, whereas no correlation between the relative protein amounts and the number of peptides and the sequence coverage was observed ( 35 ) . While spectral counting is a relatively simple and reliable technique and is easily implemented, normalization and careful statistical evaluation are still needed for accurate quanti fi cation. This accuracy can decrease signi fi cantly for proteins with only a few observable peptides, as well as when the quantitative changes between experiments are small ( 2 ) . Furthermore, since larger proteins give rise to more peptides than do smaller ones, additional normalization factors can be applied to improve the results of quanti fi cation ( 36 ) .
Absolute quanti fi cation is used to determine the absolute amount (mass, mole number, or copy number) of proteins in a mixture or complex. This is very informative, but label-based methods are usually relatively laborious and label-free ones are less accurate. Absolute quanti fi cation is generally performed at the peptide level, although top-down absolute quanti fi cation has recently been introduced ( 37 ) .
The arguably most widely used method for absolute quanti fi cation (AQUA) employs peptides labeled with heavy stable isotopes (AQUA peptides) as added, internal standards ( 29, 38 ) (see Chapter 17 ) . This method can be used for accurate pro fi ling and absolute quanti fi cation of proteins within a complex sample, for monitoring changes in posttranslational modi fi cation ( 38, 39 ) , and for determining the stoichiometry of subunits within a protein complex ( 40 ) . Being a targeted approach, the method requires a priori information about the peptides and proteins that are subject to analysis. The speci fi c characteristics of the targeted precursor ion (elution time, m / z value, charge state), optimum fragmentation conditions (collision energy), and resulting fragmentation pattern are determined in prior measurements. Peptides labeled with heavy stable isotopes ( 13 C-and 15 N-labeled amino acids), identical in sequence to the peptides of interest naturally present in the sample, are synthesized chemically. These two peptides have identical physicochemical properties but present a speci fi c mass shift in the mass spectrum. The AQUA peptides are added to the protein digest or peptide sample at known concentrations and analyzed, most commonly on triple-quadrupole instruments operated in selected reaction monitoring (SRM) mode. The co-eluting analytes-i.e., the endogenous and the mass-shifted labeled peptides-are selected for fragmentation on the basis of their (already determined) elution time and m / z value. The intensities of the fragment ions of the
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peptide of interest are compared with those of the AQUA peptide, and this re fl ects directly their quantitative relationship. As the amount of the added peptide is known, the amount of the sample peptide can be deduced.
The AQUA approach allows very speci fi c, targeted detection of the peptides of interest, thereby minimizing the variability and the in fl uence of background noise. Even in complex samples, several hundred peptides can be targeted within a single LC-MS/MS experiment ( 41 ) . As the method is strictly hypothesis-driven, it allows the selection of peptides with optimal chromatographic performance and ionization ef fi ciency (i.e., good "detectability"), which do not undergo uncontrolled modi fi cation in vitro (e.g., oxidation of methionine) and which are unique to the protein of interest. Such peptides are called prototypic peptides and can be identi fi ed or predicted for particular proteomic platform using peptide libraries and public databases (42) (43) (44) . Once established, an SRM quanti fi cation assay can be easily and reproducibly repeated for many samples.
There are several critical aspects that should be considered when an AQUA experiment is being planned such as incomplete proteolytic digestion, exact amount of AQUA peptide, application of AQUA peptides, and number of applied AQUA peptides for each protein to be quanti fi ed (see Note 6) . In order to simplify the quanti fi cation of several peptides per protein, heavy-labeled standard proteins can be used instead of individual peptides. Several approaches have been developed in that direction, including PSAQ (protein standard absolute quanti fi cation) ( 45 ) , absolute SILAC ( 46 ) , and FLEXIQuant (full-length expressed stable isotopelabeled proteins for absolute quanti fi cation) ( 47 ) (see Chapter 19 ) . QconCAT (concatenated signature peptides encoded by QconCAT genes) uses arti fi cial, labeled standard proteins assembled from diverse peptides belonging to different proteins ( 48 ) (see Chapter 18 ) . In all the protein-based approaches, the standard is added to the protein sample and subjected to protease digestion, which gives a mixture of endogenous and heavy-labeled standard peptides.
These approaches to absolute quanti fi cation have the typical advantages of label-free methods, namely (a) omitting the timeconsuming and often costly step of introducing standard peptides and (b) the opportunity to compare virtually unlimited numbers of samples. On the other hand, they entail the disadvantages of lower accuracy and the requirement for high reproducibility. One of the fi rst label-free approaches used for absolute quanti fi cation was variation of the protein abundance index (PAI ( 49 ) ). The PAI is calculated by dividing the number of observed peptides by the number of theoretically observable peptides. The emPAI (exponentially modi fi ed PAI ( 50 ) ) is de fi ned as emPAI = 10 PAI − 1; it is proportional
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to the protein content in a protein mixture and, therefore, can be used for the estimation of absolute amounts of proteins. An approach termed APEX (absolute protein expression ( 51 ) ) (see Chapter 20 ) based on spectral counting can also be used for pro fi ling absolute protein quantities per cell. Important features of APEX are the correction factors that it introduces, providing a relationship of direct proportionality between the numbers of observed and expected peptides. As incomplete digestion is a critical issue when one is performing absolute quanti fi cation of peptides or proteins, an alternative approach (generally known as "Top3") has been developed that deals with this problem. In this approach the quantities of the three most abundant tryptic peptides are averaged. It is generally assumed that some parts of the protein are completely digested and, therefore, the three most abundant peptides re fl ect the protein concentration. The protein sample is therefore spiked with a known amount of standard protein and, after digestion, the average MS signal response of the standard protein is used to calculate a universal signal response factor (ion counts per mole of protein). This factor is then applied to calculate the concentration of the proteins in the sample to be analyzed ( 52 ) .
Undoubtedly, all methods applied for absolute quanti fi cation can also be used for determining relative relations of proteins within or between samples, by comparing the absolute protein amounts in a relative manner.
1. For relative quanti fi cation using stable isotopes, the quantitative correspondence does not always apply exactly when deuterium is used as a label, as labeling with deuterium can affect retention time in LC ( 53 ) .
2. Relative quanti fi cation using stable isotope chemical or enzymatic labeling: the labeling procedure has to be optimized ensuring ideal labeling; 100% label incorporation should be aimed at, which might not be achievable for all approaches. Additionally, side reactions should be avoided to prevent erroneous quanti fi cation results.
3. Relative quanti fi cation using metabolic labeling: In general, large-scale SILAC experiments use both isotope-coded arginine and lysine to obtain labeling of all possible tryptic peptides thereby maximizing quantitative coverage of all potential peptides in a given experiment. Quanti fi cation using SILAC may be disturbed by the fact that the isotopically labeled amino acid arginine is a metabolic precursor of proline and as such might
Notes
be converted to labeled proline. As with other labeling approaches, complete incorporation of the heavy label should be aimed at (which should be limited only by the isotopic enrichment of the commercially available labeling sources).
4. Relative quanti fi cation using enzymatic labeling: Under extreme pH conditions in H 2
16
O buffers, acid-catalyzed backexchange could result in partial loss of the 18 O label. Therefore, it is recommended that the enzymatic reactions are stopped by addition of protease inhibitors or freezing of the reaction mixture, rather than by acidifying with 10% TFA.
5. Label-free quanti fi cation: The most crucial parameter in labelfree quanti fi cation is the consistent reproducibility of the LC separation, ionization, and mass measurements of the peptides. All variations of peptide intensities, as well as LC retention times should be recorded between technical replicates and used for normalization and alignment between runs.
6. Absolute quanti fi cation: First of all, when peptides from protease digests are to be quanti fi ed, complete digestion of the protein sample must be guaranteed. Missed protease cleavages affecting the targeted peptide will result in an arti fi cial decrease in the amounts observed in quanti fi cation. Additionally, AQUA peptides are usually obtained in known absolute amounts in lyophilized form, and therefore have to be dissolved quantitatively. As it is advisable to add standard peptides after rather than before digestion ( 54 ) , any variability and losses during the prior sample preparation should be minimized. Finally, for reliable quanti fi cation results, several peptides per targeted protein should be monitored, in order to provide more than one reference value per protein.
